Table 1 Clinical features of nasal natural killer/T‐cell lymphomas.
Case | Age/sex | Tumour involvement | Clinical stage | Treatment | Response | Survival period, months | Outcome |
---|---|---|---|---|---|---|---|
1 | 62/F | Nose | I | CT | Failure | 5 | Died |
2 | 24/F | Nose | I | CT and RT | Failure | 4 | Died |
3 | 52/F | Nose | I | CT | Failure | 22 | Alive |
4 | 40/M | Nose | I | CT | CR | 12 | Alive |
5 | 28/M | Nasopharynx, supraglotis, stomach | IV | CT | Failure | 1 | Died |
6 | 58/F | Nose | I | NA | NA | NA | NA |
7 | 53/F | Nose (at 46 months) | I | CT and RT | CR | 52 | Relapsed |
8 | 43/M | Hard palate, orbit, ethmoid | II | CT | CR | 14 | Died |
9 | 26/M | Nose | I | CT | CR | 7 | Died |
CR, complete remission; CT, chemotherapy; F, female; M, male; NA, not available; RT, radiotherapy.